World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
130
Citations
70151
World Ranking
2476
National Ranking
1396

Stephen D. Silberstein publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Stephen D. Silberstein sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 690 publications — 80th percentile

80% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Stephen D. Silberstein D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Stephen D. Silberstein sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 130 D-Index — 88th percentile

88% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Stephen D. Silberstein is affiliated with Thomas Jefferson University in the United States. Their research primarily focuses on medicine, with significant contributions in psychiatry and mental health, pathology and forensic medicine, neurology, physiology, and molecular biology.

Silberstein's work spans several main topics including:

  • Migraine and Headache Studies
  • Trigeminal Neuralgia and Treatments
  • Sympathectomy and Hyperhidrosis Treatments
  • Botulinum Toxin and Related Neurological Disorders
  • Ophthalmology and Eye Disorders
  • Psychosomatic Disorders and Their Treatments
  • Cerebral Venous Sinus Thrombosis

Their recent publications cover significant migraine research, including:

  • Mechanism of Action of OnabotulinumtoxinA in Chronic Migraine: A Narrative Review, 2020, Headache The Journal of Head and Face Pain
  • Long-term efficacy and safety of erenumab in migraine prevention: Results from a 5-year, open-label treatment phase of a randomized clinical trial, 2021, European Journal of Neurology
  • Long-term safety, tolerability, and efficacy of fremanezumab in migraine, 2020, Neurology
  • Chronic versus episodic migraine: The 15-day threshold does not adequately reflect substantial differences in disability across the full spectrum of headache frequency, 2021, Headache The Journal of Head and Face Pain
  • Pooled Analysis of PFO Occluder Device Trials in Patients With PFO and Migraine, 2021, Journal of the American College of Cardiology

Frequent coauthors in Silberstein's research include:

  • David W. Dodick
  • Richard B. Lipton
  • Peter J. Goadsby
  • Hsiangkuo Yuan
  • Joshua M. Cohen

Silberstein has published extensively in a few key journals, including:

  • Neurology (18 publications)
  • Headache The Journal of Head and Face Pain (13 publications)
  • Pain and Therapy (3 publications)
  • European Journal of Neurology (2 publications)
  • Journal of the American College of Cardiology (2 publications)

Their research contributions span a broad range of neurological and headache-related conditions, with an emphasis on clinical studies of migraine mechanisms, preventive treatments, and associated neurological disorders.

Best Publications

  • The International Classification of Headache Disorders, 3rd edition (beta version)

    Jes Olesen;André Bes;Robert Kunkel;James W. Lance

  • Practice parameter: Evidence-based guidelines for migraine headache (an evidence-based review) Report of the Quality Standards Subcommittee of the American Academy of Neurology

    Stephen D. Silberstein

  • OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial

    HC Diener;DW Dodick;SK Aurora;CC Turkel

  • New Appendix Criteria Open for a Broader Concept of Chronic Migraine

    J. Olesen;M -G Bousser;H -C Diener;D. Dodick

  • OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double-Blind, Randomized, Placebo-Controlled Phases of the PREEMPT Clinical Program

    David W. Dodick;Catherine C. Turkel;Ronald E. Degryse;Sheena K. Aurora

  • Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults Report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society

    S.D. Silberstein;S. Holland;F. Freitag;D.W. Dodick

  • Fremanezumab for the Preventive Treatment of Chronic Migraine

    Stephen D. Silberstein;David W. Dodick;Marcelo E. Bigal;Paul P. Yeung

  • Classification of daily and near-daily headaches: Field trial of revised IHS criteria

    Stephen D. Silberstein;Richard B. Lipton;Martin John Sliwinski

  • Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial

    Stewart Tepper;Messoud Ashina;Uwe Reuter;Jan L Brandes

  • Botulinum Toxin Type A as a Migraine Preventive Treatment

    Stephen Silberstein;Ninan Mathew;Joel Saper;Stephen Jenkins

  • Premonitory symptoms in migraine: an electronic diary study.

    N. J. Giffin;L. Ruggiero;R. B. Lipton;S. D. Silberstein

  • Topiramate in Migraine Prevention: Results of a Large Controlled Trial

    Stephen D. Silberstein;Walter Neto;Jennifer Schmitt;David Jacobs

  • Classification of Daily and Near‐Daily Headaches: Proposed Revisions to the IHS Criteria

    Stephen D. Silberstein;Richard B. Lipton;Seymour Solomon;Ninan T. Mathew

  • Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.

    Stephen D. Silberstein;Richard B. Lipton;David W. Dodick;Frederick G. Freitag

  • Cutaneous allodynia in the migraine population.

    Richard B. Lipton;Marcelo E. Bigal;Sait Ashina;Rami Burstein

  • The Acute Treatment of Migraine in Adults: The American Headache Society Evidence Assessment of Migraine Pharmacotherapies

    Michael J. Marmura;Stephen D. Silberstein;Todd J. Schwedt

  • Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trial

    Richard B Lipton;David W Dodick;Stephen D Silberstein;Joel R Saper

  • Occipital nerve stimulation for the treatment of intractable chronic migraine headache: ONSTIM feasibility study.

    Joel R Saper;David W Dodick;Stephen D Silberstein;Sally McCarville

  • Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine: A Randomized Clinical Trial.

    David W. Dodick;Stephen D. Silberstein;Marcelo E. Bigal;Paul P. Yeung

  • The International Classification of Headache Disorders, 2nd Edition (ICHD-II)--revision of criteria for 8.2 Medication-overuse headache.

    Stephen D. Silberstein;J. Olesen;M. G. Bousser;H. C. Diener

Frequent Co-Authors

Richard B. Lipton
Richard B. Lipton Albert Einstein College of Medicine
David W. Dodick
David W. Dodick Mayo Clinic
Peter J. Goadsby
Peter J. Goadsby King's College London
Hans-Christoph Diener
Hans-Christoph Diener University of Duisburg-Essen
Stewart J. Tepper
Stewart J. Tepper Dartmouth College
Marcelo E. Bigal
Marcelo E. Bigal Albert Einstein College of Medicine
Messoud Ashina
Messoud Ashina University of Copenhagen
Rami Burstein
Rami Burstein Beth Israel Deaconess Medical Center
Shuu-Jiun Wang
Shuu-Jiun Wang National Yang Ming Chiao Tung University
Jes Olesen
Jes Olesen University of Copenhagen

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a medical career in the USA is not limited to traditional MD programs. Many prospective healthcare professionals are turning to flexible online degrees to accelerate their careers and specialize in high-demand fields. For nurses looking to advance their qualifications quickly, options like the 1 year dnp program online offer an efficient path to a Doctor of Nursing Practice degree.

Those seeking less rigorous commitments may prefer programs highlighted among the easiest online dnp programs, balancing work and study without compromising quality. For individuals aiming to enter the nursing field rapidly, 6 month lpn program options provide a fast track to licensure and employment.

Mental health remains a critical area in healthcare. If psychiatric care is your focus, consider specialized fast-track opportunities such as the fast track mental health nursing degrees. These online programs are designed to help you progress swiftly into fulfilling and in-demand medical roles, supporting both your career goals and the evolving needs of patients nationwide.

Best Scientists Citing Stephen D. Silberstein

Trending Scientists

Recently Published Articles